Sponsor or institution
Clinical trials and research at Nabgen, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
New way to block antibodies that stop AAV gene therapy
A new approach uses a special protein to block antibodies that prevent AAV gene therapies from working in people.
-
Universal approach to block inhibitors in protein replacement therapy for AAV-based treatments
A new approach aims to block immune inhibitors that reduce the effectiveness of protein therapies used in conditions like hemophilia and certain storage diseases.
-
Stopping antibodies that block AAV gene therapy
A protein-based approach aims to block the antibodies that stop AAV gene therapies so more patients can benefit from AAV treatments.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.